Gastroenterology and Hepatology - Crohn's Colitis Professional

1-16 of 69

IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CE
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD; Ugo Iroku, MD, MHS
0.50 credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
0.50 credits
MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD; Michael Dolinger, MD, MBA
2.00 credits 13 episodes
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 credits 13 episodes
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
MinuteCE®
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Florence Odufalu, MD; David T. Rubin, MD
2.00 program credits
- Florence Odufalu, MD
- David T. Rubin, MD
2.00 program credits
The Future of Biologic Treatment in IBD: What’s on the Horizon
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®
The Future of Biologic Treatment in IBD: What’s on the Horizon
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Putting It All Together: A Practical IBD Treatment Selection Primer
Putting It All Together: A Practical IBD Treatment Selection Primer
MinuteCE®
Putting It All Together: A Practical IBD Treatment Selection Primer
Ugo Iroku, MD, MHS; Michael Dolinger, MD, MBA
2.00 program credits
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Navigating IBD Guidelines: What Clinicians Need to Know Now
Navigating IBD Guidelines: What Clinicians Need to Know Now
MinuteCE®
Navigating IBD Guidelines: What Clinicians Need to Know Now
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Translating Advances into Practice: Lessons from Today’s IBD Landscape
MinuteCE®
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Ugo Iroku, MD, MHS; David T. Rubin, MD
2.00 program credits
- Ugo Iroku, MD, MHS
- David T. Rubin, MD
2.00 program credits
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
MinuteCE®
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Michael Dolinger, MD, MBA; Florence Odufalu, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
2.00 program credits
The Evolving Role of Small Molecules in IBD Care
The Evolving Role of Small Molecules in IBD Care
MinuteCE®
The Evolving Role of Small Molecules in IBD Care
Florence Odufalu, MD; David T. Rubin, MD
2.00 program credits
- Florence Odufalu, MD
- David T. Rubin, MD
2.00 program credits
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
MinuteCE®
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Defining Success in IBD: Treat-to-Target
Defining Success in IBD: Treat-to-Target
MinuteCE®
Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD; Ugo Iroku, MD, MHS
2.00 program credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 program credits
Where Conventional IBD Therapies Fall Short
Where Conventional IBD Therapies Fall Short
MinuteCE®
Where Conventional IBD Therapies Fall Short
Ugo Iroku, MD, MHS; Michael Dolinger, MD, MBA
2.00 program credits
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
2.00 program credits
Setting the Stage: Why Rethinking IBD Care Matters Now
Setting the Stage: Why Rethinking IBD Care Matters Now
MinuteCE®
Setting the Stage: Why Rethinking IBD Care Matters Now
Florence Odufalu, MD; Ugo Iroku, MD, MHS
2.00 program credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
2.00 program credits
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
CME/CE
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
David T. Rubin, MD; Michael Dolinger, MD, MBA
0.25 credits
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
0.25 credits

Prev
1
2
3
4
5
Next

1/5